Interestingly, GLP-1 receptors (GLP-1R) have also been found in the brain, specifically in the hippocampus, hypothalamus, cerebral cortex, and olfactory bulbs [88], thus increasing interest in the use of GLP-1 analogues as a potential therapeutic in AD. The gene discussed is GCG; the disease is Alzheimer disease.